neostigmine methylsulfate
Generic: neostigmine methylsulfate
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
neostigmine methylsulfate
Generic Name
neostigmine methylsulfate
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
neostigmine methylsulfate 1 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
76045-214
Product ID
76045-214_27e94d4f-f8d8-437a-a770-7020a9f8f61d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA203629
Listing Expiration
2026-12-31
Marketing Start
2018-09-18
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76045214
Hyphenated Format
76045-214
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
neostigmine methylsulfate (source: ndc)
Generic Name
neostigmine methylsulfate (source: ndc)
Application Number
NDA203629 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1 mg/mL
Packaging
- 10 BLISTER PACK in 1 CARTON (76045-214-30) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-214-00) / 3 mL in 1 SYRINGE, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "27e94d4f-f8d8-437a-a770-7020a9f8f61d", "openfda": {"unii": ["98IMH7M386"], "rxcui": ["2105413"], "spl_set_id": ["b0b509c3-8dc8-48cc-b7a8-16b93ad706c6"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 CARTON (76045-214-30) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-214-00) / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "76045-214-30", "marketing_start_date": "20220601"}], "brand_name": "Neostigmine Methylsulfate", "product_id": "76045-214_27e94d4f-f8d8-437a-a770-7020a9f8f61d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "76045-214", "generic_name": "Neostigmine Methylsulfate", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neostigmine Methylsulfate", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": "1 mg/mL"}], "application_number": "NDA203629", "marketing_category": "NDA", "marketing_start_date": "20180918", "listing_expiration_date": "20261231"}